Table 2.
Levels of traditional and candidate markers in studied groups
| Study groups | CEA (ng/ml) | CA19.9 (μ/ml) | PLR | SCF (ng/ml) | LRG1 (μg/ml) | SCF-LRG1 (μg/ml) |
|---|---|---|---|---|---|---|
| Healthy subjects | 43.1 ± 14.0 | 98.1 ± 32.2 | 4.8 ± 2.2 | 231.9 ± 33.2 | 39.6 ± 16.3 | 3.1 ± 0.64 |
| Benign | 88.8 ± 21.8 | 118.7 ± 37.5 | 5.2 ± 2.3 | 440.1 ± 35.4 | 44.6 ± 8.7 | 3.6 ± 0.38 |
| CRC | 47.7 ± 13.5 | 108.5 ± 34.2 | 5.0 ± 2.2 | 605.7 ± 38.5 | 52.5 ± 16.9 | 4.6 ± 1.3 |
| p value a | 0.349 | 0.216 | 0.025 | 0.001 | 0.0001 | 0.0001 |
| Non-treated CRC | 40.1 ± 33.7 | 155.9 ± 49.3 | 6.2 ± 2.1 | 1185.3 ± 39.5 | 69.3 ± 12.0 | 5.3 ± 1.6 |
| Treated CRC | 26.0 ± 22.2 | 68.6 ± 48.3 | 4.2 ± 1.9 | 530.2 ± 39.1 | 54.2 ± 13.2 | 4.0 ± 0.59 |
| p valueb | 0.978 | 0.167 | 0.014 | 0.019 | 0.001 | 0.001 |
aFor discriminating among studied groups
bFor discriminating between non-treated and treated CRC groups